Overes, Maribel A.
HRN: 21-00-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
MEBENDAZOLE 500MG (TAB)
05/25/2022
06/01/2022
ORAL
500mg
Q8
S/P LTCS ; Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Choice
Overall appropriateness: No Wrong Choice